RecruitingNCT04185779
COLO-COHORT (Colorectal Cancer Cohort) Study
Sponsor
South Tyneside and Sunderland NHS Foundation Trust
Enrollment
15,000 participants
Start Date
Dec 13, 2019
Study Type
OBSERVATIONAL
Conditions
Summary
This is a cross-sectional study aimed at identifying factors which best predicts patients at high risk of colorectal cancer or colorectal adenomas and to develop a risk prediction model.
Eligibility
Min Age: 18 Years
Inclusion Criteria10
- Group A
- Aged ≥30 years\* and able to give informed consent
- Patients attending colonoscopy
- Through Bowel Cancer Screening Programme (FIT positive, Bowelscope conversion, surveillance)
- Through standard NHS care (most commonly due to iron deficiency anaemia, altered bowel habit, weight loss, rectal bleeding, planned polypectomy\*\*, those referred on basis of family history, abnormal cross-sectional imaging, polyp surveillance or post CRC surveillance)
- The age of 30 was chosen to ensure that this is a population likely to be enriched for colorectal neoplasia with neoplasia below this age uncommon \*\*In those attending for planned polypectomy, the results from the initial colonoscopy and the endoscopy where the polypectomy is undertaken will be summated for purposes of calculating the neoplasia profile
- (COLO-SPEED) Group B
- Any patient attending for colonoscopy and able to give informed consent
- ≥ 18 years old
- Patient from the North of England
Exclusion Criteria11
- Group A
- Unable to give informed consent
- Known polyposis syndrome
- Previous total colectomy
- Known colonic stricture which would limit complete colonoscopy
- Attending for planned therapeutic procedure other than polypectomy, such as insertion of colonic stent
- Attending for assessment of known inflammatory bowel disease (IBD) activity or for IBD surveillance
- Patients currently recruited into an interventional CTIMP for CRC prevention\*
- COLO-SPEED (Group B) \*\*
- Unable to give informed consent
- Not in a centre supported by COLO-SPEED infrastructure (North of England)
Interventions
DIAGNOSTIC_TESTColonoscopy
Diagnostic colonoscopy
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04185779
Related Trials
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
NCT0546403035 locations
Prospective Clinical Validation of Next Generation Sequencing (NGS) and Patient-Derived Tumor Organoids (PDO) Guided Therapy in Patients With Advanced/ Inoperable Solid Tumors
NCT060775911 location
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
NCT0701157614 locations
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
NCT0697316127 locations
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
NCT0624477126 locations